Health is becoming an increasingly influential part of everyday life, shaping how people seek information, make decisions, and experience care. In a recent Adweek House HQ Group Chat, leaders from Publicis Health, Digitas Health, and across the industry explored how human-centered creativity, trusted data, and AI are redefining the future of healthcare.

In Part Two of The Future of Brand.com roundtable hosted by The DHC Group, Publicis Health's Stephanie Schulman and Heartbeat's Dan Haller joined industry leaders to explore how AI is reshaping patient discovery, engagement, and trust. The discussion highlighted why brand websites must now serve both human and AI audiences, deliver value beyond information alone, and provide the trusted resources patients need to take meaningful next steps. The future of brand.com is not disappearing. It's becoming more essential than ever.

Langland’s team at White City Innovation District explores how strategy, creativity and medical science come together to tackle healthcare challenges. The conversation also highlights how innovation, diverse perspectives and emerging technologies like AI are shaping the future of healthcare communications.

AI is streamlining the medical publication lifecycle, from evidence discovery and planning to content development and peer review, while human expertise remains essential for scientific accuracy and integrity.

The future of pharma marketing is shifting as health decisions increasingly happen across social feeds, private chats, creator content, and AI-powered conversations. Success will depend on meeting patients in trusted spaces, using predictive measurement, and supporting them throughout the full patient journey—not just at the point of prescription.

Publicis Health's Chief Content Enablement Officer, Stephanie Schulman and Heartbeat's EVP of Engagement Strategy, Dan Haller joined leaders from across healthcare, pharma, and technology for The DHC Group's Consumer AI Roundtable, hosted by Mark Bard, to discuss how brands can help shape a more trusted information ecosystem and support better patient conversations in an AI-driven world.

Rapid policy shifts from ASCO and CMS have thrust the 340B program into the spotlight, signaling a fundamental debate over who should benefit from drug savings and where cancer care will be delivered. As reimbursement pressures mount and stakeholders push back, health systems, payers, and providers must quickly adapt to a changing market that will reshape access, site-of-care decisions, and commercial strategy.

Breakthrough data at ASCO 2026 underscored a new reality in oncology: scientific innovation alone isn’t enough—early, strategic planning for market access is now critical to ensuring therapies reach patients. As treatments grow more complex, success will depend on how well manufacturers address biomarker readiness, real-world adherence, and payer expectations from the outset.

In this conversation with The DHC Group's Mark Bard, Craig Romanok, Chief Commercial Officer at Digitas Health/Publicis Health, reflects on three decades of change in pharma marketing and the trends shaping its future. From the rise of health consumers to the promise of AI, Craig discusses why creativity continues to drive meaningful impact and why a multi-dimensional approach to AI will define tomorrow's industry leaders.

As procurement becomes a strategic driver of growth rather than a gatekeeper of cost, healthcare organisations have an opportunity to rethink how marketers, procurement teams and agencies create value together. Annabelle Sandeman explores why stronger partnerships are the industry's next competitive advantage.

Operations leader joins agency to strengthen delivery excellence, scale collaboration, and advance connected ways of working across Digitas Health.  

At Cannes Lions, “Culture as Care: Embedding Health Where It Lives” challenged brands to stop waiting for patients and start showing up in everyday life. With perspectives from Novartis, Pinterest, and Digitas Health, the panel made one thing clear: when health aligns with culture, it becomes more relevant, engaging, and impactful.

Cannes Lions 2026 revealed a clear shift in marketing: success now comes from creating meaningful, real-world impact rather than just delivering messages. Across campaigns and conversations, brands proved that authenticity, cultural relevance, and bold action—not fear or polish—are what truly drive connection and lasting change.

At Cannes Lions 2026, one message stood out: in today’s landscape, success isn’t about what brands say, but what they make people feel and remember. For health brands, that means moving beyond clarity to create culturally resonant, behavior-shifting work that delivers real-world impact.

At Cannes Lions 2026, Matt McNally joined ADWEEK’s Leadership Voices to share his perspective on where healthcare is headed and how Publicis Health is built for the future. From the growing demand for more connected, human-centered solutions to the power of bringing data, creativity, and expertise together, the conversation highlighted what it takes to lead in a rapidly evolving industry.

At Cannes Lions, it was clear that healthcare marketing is moving beyond rigid annual plans toward more dynamic, always-on approaches. In ADWEEK House’s From Static Planning to Living Systems session, leaders including Elle McComsey highlighted the shift to adaptive, data-driven ecosystems that continuously learn and respond in real time.

Attending ASCO 2026 underscored both the meaningful progress in gynecologic cancer care and the urgent need for greater awareness. For many women in mid-life, menopause symptoms can mirror early warning signs of cancer—often leading to delayed diagnoses in the absence of reliable screening options.

ASCO 2026 reinforced that while scientific innovation continues to advance oncology, the real impact lies in addressing the everyday barriers patients face in accessing and navigating care. From poster sessions to policy discussions, the meeting highlighted the critical need to translate breakthroughs into more equitable, patient-centered outcomes.

A recent MM+M article, authored by Fannie McWatt and Adriano Botter, examines how AI is shifting from a marketing tool to an active “audience,” changing how brands compete for visibility, credibility, and influence in AI-driven decision-making environments.

Payer Sciences ranks #66 on MM+M’s 2026 Agency 100 list, recognized for its specialized market access expertise and ability to turn complex payer insights into actionable strategy. By combining analytics, AI, and a deeply integrated Publicis Health model, the agency is helping brands navigate access challenges and drive smarter, more effective healthcare decisions.